Today, September 18, 2025 the Centers for Disease Control and Prevention released the Morbidity and Mortality Weekly Report (MMWR) for the clinical recommendation of another injectable medication for PrEP. Lenacapavir is an injectable medication given every 6 months and the results of 2 clinical trials showed 100% efficacy at reducing HIV infection in females.
